FibroGen, Inc (FGEN) is a publicly traded Healthcare sector company. As of August 13, 2026, FGEN trades at $9.71 with a market cap of $39.28M and a P/E ratio of -20.23. FGEN moved +5.20% today. Year to date, FGEN is +35.05%; over the trailing twelve months it is -41.77%. Its 52-week range spans $4.85 to $21.94. Analyst consensus is hold with an average price target of $28.00. Rallies surfaces FGEN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest FGEN news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $9.71 |
| Market Cap | $39.28M |
| P/E Ratio | -20.23 |
| EPS | $-0.48 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.94 |
| 52-Week Low | $4.85 |
| Volume | 34.03K |
| Avg Volume | 0 |
| Revenue (TTM) | $29.62M |
| Net Income | $-47.58M |
| Gross Margin | 47.47% |
14 analysts cover FGEN: 0 strong buy, 5 buy, 7 hold, 2 sell, 0 strong sell. Consensus rating is hold. Average price target: $28.00.